McKinley Carter Wealth Services’s NervGen Pharma NGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$62.4K Hold
32,653
– – ﹤0.01% 321
2026
Q2
$67.3K Buy
32,653
+1,761
+6% +$5.46K ﹤0.01% 320
2026
Q1
$116K Buy
+30,892
New +$134K 0.01% 303

Other funds holding NGEN

McKinley Carter Wealth Services's NGEN Position: Q3 2026 in Review

McKinley Carter Wealth Services held its NervGen Pharma (NGEN) position steady in Q3 2026 at 32,653 shares worth $62.4K. The position accounts for ﹤0.01% of the portfolio, ranked #321.

McKinley Carter Wealth Services first reported a position in NGEN in Q1 2026 and has held it in 3 quarters since. The position peaked at $116K in Q1 2026. 68 funds tracked by Wall St. Rank hold NGEN as of Q3 2026.

  • McKinley Carter Wealth Services held 32,653 shares of NervGen Pharma worth $62.4K as of Q3 2026.
  • McKinley Carter Wealth Services left its NervGen Pharma share count unchanged in Q3 2026.
  • NervGen Pharma made up ﹤0.01% of McKinley Carter Wealth Services's portfolio in Q3 2026, its #321 holding.
  • McKinley Carter Wealth Services first reported a position in NervGen Pharma in Q1 2026 and has held it in 3 quarters since.
  • McKinley Carter Wealth Services's NervGen Pharma position peaked at $116K in Q1 2026.
  • 68 funds tracked by Wall St. Rank held NervGen Pharma as of Q3 2026.

Based on McKinley Carter Wealth Services's 13F filing for Q3 2026, filed 16 Oct 2026.